Latest Operational Costs News

Page 126 of 136
Australian Bond Exchange Holdings reports a halving of its operating cash flow shortfall in Q2 FY25, driven by a successful cost reduction program and the launch of a new market-linked security. The company is accelerating its AI initiatives to enhance compliance and transaction efficiency.
Claire Turing
Claire Turing
31 Jan 2025
Vertex Minerals has completed construction and begun commissioning of its Gravity Gold plant at the Reward Gold Mine, supported by significant capital raises and strategic hires.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Tasman Resources has identified six promising drill targets at its Parkinson Dam gold project in South Australia, supported by advanced geophysical analysis and a new high-resolution gravity survey. The company also highlights ongoing investment in Eden Innovations and strategic funding moves.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Po Valley Energy Limited reports a robust December 2024 quarter marked by rising gas production, strong revenue growth, and significant progress in exploration and development across its Italian assets.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Far Northern Resources reports promising assay results from its Rocks Reef and Empire projects in North Queensland, setting the stage for intensified exploration and drilling activities in 2025.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Australian Vanadium Limited reports significant progress in its integrated vanadium supply chain, including government approvals, Project Lumina development, and successful vanadium flow battery deployment.
Maxwell Dee
Maxwell Dee
31 Jan 2025
InFocus Group Holdings has marked a pivotal quarter with a major $2.5 million contract in digital gaming and a corporate rebrand signaling its shift to enterprise software and analytics. The imminent Prodigy9 acquisition and capital raise position the company for accelerated growth.
Sophie Babbage
Sophie Babbage
31 Jan 2025
Uscom Limited reports a 56% increase in cash on hand to $2.17 million for Q2 2024, driven by strategic moves in China and new product regulatory approvals.
Victor Sage
Victor Sage
31 Jan 2025
Mesoblast has secured FDA approval for Ryoncil®, the first mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease in children, while raising A$260 million to accelerate clinical trials and commercial rollout.
Ada Torres
Ada Torres
31 Jan 2025
Eden Innovations Ltd reports a striking 158% increase in US OptiBlend® sales for Q2 FY25, alongside expanding international traction for its EdenCrete® products and strategic property sales aimed at debt reduction.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Meteoric Resources NL has reported a significant update to its Caldeira Rare Earth Project, highlighting improved financial metrics and exceptional drilling results that reinforce its position as a low-cost rare earths producer.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Province Resources Limited reported a stable cash position of $9.27 million in its December 2024 quarter, while continuing discussions on its HyEnergy® project and evaluating new gold and commodity opportunities.
Maxwell Dee
Maxwell Dee
31 Jan 2025